For Clinics
Biologics & Regenerative Devices.
FDA-Compliant. Fully Documented.
Amniotic, umbilical, and exosome biologics alongside acellular joint support devices — all sourced from FDA-registered facilities and distributed exclusively to licensed healthcare providers. Full chain-of-custody and HCT/P compliance records with every order.
Product Categories
Regenerative products for
licensed clinical application.
Amniotic Biologics
FDA-compliant amniotic tissue products sourced from accredited tissue banks with full regulatory documentation and chain-of-custody verification. Suitable for soft tissue and wound care protocols.
Umbilical Cord Biologics
Umbilical cord-derived products for regenerative medicine applications. Licensed providers only. Complete HCT/P documentation included with every shipment.
Exosome Products
Exosome-based biologics for research and clinical protocol use. Sourced from FDA-registered facilities with documented sterility and identity testing.
HX25® Acellular Intra-Articular Device
A sterile, acellular, protein-based intra-articular injectable device for musculoskeletal and joint support. Classified as a medical device — not a drug or biologic. Manufactured without viable cells, tissue fragments, or pharmacologically active agents.
Featured Device
HX25® Acellular
Intra-Articular Device.
Powered by Nuvyra Life, HX25® is a sterile, acellular, protein-based injectable device developed specifically for musculoskeletal and joint support applications. It is formally classified as a medical device — not a drug, biologic, or pharmaceutical product. HX25® achieves its intended purpose through the physical supplementation of the intra-articular environment, not through pharmacological, immunological, or metabolic means.
The device is designed to physically supplement the synovial environment by introducing a defined protein composition consistent with naturally occurring joint fluid components — acting as a compositional supplement to support the structural and physical properties of the intra-articular space.
Physical Mechanism of Action
Compositional Supplementation
Physically replenishes protein components naturally present in healthy human synovial fluid but diminished or altered in degenerative or stressed joints.
Structural Matrix Support
Provides an acellular protein matrix that supplements the physical environment of the joint space, supporting structural integrity.
Synovial Environment Conditioning
Conditions the joint space by supplementing its native composition — working with the body's existing environment rather than against it.
Fluid Volume & Composition
Supplements the volume and protein composition of synovial fluid in joints where natural fluid quality or quantity has been compromised.
HX25® does not achieve its primary intended purpose through pharmacological action, cellular activity, or metabolic processing.
Clinical Applications
HX25® may be considered for use in patients presenting with the following conditions. Clinical use and treatment frequency should be determined by the treating physician based on patient-specific evaluation.
- Degenerative joint disease and osteoarthritis
- Joint inflammation and synovitis
- Early cartilage degeneration with compromised synovial fluid quality
- Post-arthroscopic joint support
- Joint stress in athletic or physically active populations
- Chronic joint discomfort inadequately managed by conservative care alone
Administration Protocol
Prepare
Sterile unit per manufacturer guidelines. Inspect packaging for damage or tampering prior to use.
Inject
Administer directly at the anatomical site using aseptic technique. Each unit is for single use in a single joint.
Monitor
Record patient comfort post-procedure. Document lot number, injection site, and volume administered.
Follow-Up
Repeat as indicated per physician-directed treatment plan. HX25® is intended to complement — not replace — standard physician-directed musculoskeletal care.
Precautions
Administer using strict aseptic technique. Transient post-injection swelling, warmth, or discomfort may occur and is generally self-limiting. Discontinue and initiate clinical evaluation if signs of infection or worsening symptoms develop. Safety and effectiveness have not been established in pregnant, nursing, or pediatric populations. Do not mix HX25® with other injectable products in the same syringe.
Full chain-of-custody. Every product.
Every order. No exceptions.
Who We Serve
Built for clinicians who take
compliance as seriously as outcomes.
Regenerative Medicine Practices
Physicians building comprehensive regenerative protocols benefit from a single trusted source for amniotic, umbilical, and exosome products alongside joint support devices — all fully documented.
Orthopedic & Sports Medicine
The HX25® intra-articular device is purpose-built for orthopedic applications. Physical mechanism, acellular composition, and clear device classification make it straightforward to integrate into existing protocols.
Pain Management Clinics
Patients who have exhausted conservative care options and are managing chronic joint discomfort are ideal candidates for physician-directed biologic and device protocols.
Anti-Aging & Longevity Practices
Exosome and amniotic biologics fit naturally alongside longevity-focused treatment menus for practices serving health-optimization patients.
Functional Medicine Providers
Whole-body, root-cause practitioners increasingly incorporate regenerative tools for musculoskeletal health, inflammation management, and tissue support.
Compliance & Documentation
The documentation burden
is ours to carry.
All biologic products are distributed in compliance with FDA 21 CFR Part 1271 (HCT/P regulations). Access is restricted to licensed healthcare providers with valid NPI numbers. Full chain-of-custody, certificate of conformance, and applicable regulatory documentation is provided with every order.
Golden Lotus Labs does not make claims that any product treats, cures, or prevents any medical condition. Clinical decisions remain entirely with the treating physician.
FDA 21 CFR Part 1271
All HCT/P products distributed in full compliance with federal tissue regulations.
Accredited Tissue Banks
Source facilities are FDA-registered and AATB-accredited. No exceptions.
Chain-of-Custody Documentation
Certificate of conformance, lot traceability, and sterility records shipped with every order.
Licensed Providers Only
Valid NPI required. We do not distribute to unlicensed individuals or non-clinical entities.
Medical Device Classification
HX25® is formally classified as a medical device — physical mechanism only, no pharmacological or cellular activity.
No Unsubstantiated Claims
We do not represent that any product treats, cures, or prevents any medical condition.
Partner with a compliant biologics distributor.
Licensed providers only. Apply today to access our biologics and device catalog with full documentation.